Appetite Regulation in Children With Failure to Thrive
NCT02647580 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2017-07-25
Summary
Failure to thrive (FTT) is an expression for inadequate growth in the early childhood and thus, a sign of undernutrition. This study will include children with FTT, and compare with existing data from children with normal and excessive growth.
The overall aim of this study is to explore whether 1) children who develop FTT with no organic explanation differ from healthy normal weight and overweight children in their basal level of appetite-regulating hormones and 2) if inadequate, normal and excessive growth in children can be partly predicted by variation in their gut microbiome and metabolome.
Conditions
- Failure to Thrive
Sponsors & Collaborators
-
Hvidovre University Hospital
collaborator OTHER -
Technical University of Denmark
collaborator OTHER -
Lena Kirchner Brahe
lead OTHER
Eligibility
- Min Age
- 12 Months
- Max Age
- 36 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2017-06-30
- Completion
- 2017-06-30
Countries
- Denmark
Study Locations
More Related Trials
-
Ghrelin Levels in Children With Poor Growth
NCT01070173 ·Status: COMPLETED
-
Effects of Growth Hormone (GH) Treatment on Eating Regulation
NCT00562705 ·Status: COMPLETED ·Phase: NA
-
Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation
NCT01734447 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Growth Hormone in Children With Growth Hormone Deficiency
NCT00262249 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease
NCT00194961 ·Status: TERMINATED ·Phase: PHASE4
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
NCT00362063 ·Status: UNKNOWN ·Phase: NA
-
Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone
NCT01626833 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)
NCT01438801 ·Status: WITHDRAWN ·Phase: PHASE4
-
Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency
NCT00646815 ·Status: COMPLETED ·Phase: NA
-
Natural History Study of Patients With Excess Androgen
NCT00250159 ·Status: RECRUITING
-
Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
NCT01237041 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)
NCT02507245 ·Status: COMPLETED
-
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 ·Status: COMPLETED ·Phase: PHASE2
-
IGF1 Generation Test
NCT00145457 ·Status: COMPLETED ·Phase: PHASE4
-
Phase II Study of Growth Hormone in Children With Cystic Fibrosis
NCT00016445 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood
NCT00212758 ·Status: COMPLETED ·Phase: PHASE4
-
Growth Response in Girls With Turner Syndrome
NCT01734486 ·Status: COMPLETED ·Phase: PHASE4
-
Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation
NCT01697644 ·Status: COMPLETED ·Phase: PHASE4
-
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
NCT00187993 ·Status: UNKNOWN
-
National Cooperative Growth Study in CKD
NCT00616278 ·Status: COMPLETED
-
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513 ·Status: COMPLETED
-
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
NCT02616562 ·Status: COMPLETED ·Phase: PHASE2
-
Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy
NCT03225755 ·Status: COMPLETED
-
Fitness Level in Short Stature Children and After Growth Hormone Treatment
NCT02977091 ·Status: UNKNOWN